Keyphrases
In Situ
100%
In Situ Hybridization
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Cervical Lesions
100%
Monoclonal Antibody
66%
Immunocytochemistry
66%
Capsid Protein
33%
HPV16
33%
Diagnostic Sensitivity
33%
Biopsy Specimen
16%
HPV Types
16%
Human Detection
16%
Direct Detection
16%
HPV33
16%
Relative Sensitivity
16%
HPV18
16%
Immunology and Microbiology
Wart Virus
100%
In Situ Hybridization
100%
Monoclonal Antibody
66%
Immunocytochemistry
66%
Capsid
33%
Human Papillomavirus Type 16
33%
Human Papillomavirus Type 18
16%
Human Papillomavirus Type 33
16%
Immunology
16%
Nursing and Health Professions
Sensitivity and Specificity
100%
In Situ Hybridization
100%
Monoclonal Antibody
66%
Immunocytochemistry
66%
Capsid Protein
33%
Diagnosis
16%
Biopsy Technique
16%
Neuroscience
In Situ Hybridization
100%
Human Papillomavirus
100%
Immunocytochemistry
66%
Monoclonal Antibody
66%
Capsid Protein
33%